8th Medicon Valley Inhalation Symposium

Future Opportunities of Inhalation – Final Program.

When: 9th–10th October 2019, 08.30–17.30, 08.30–13.00
Where: Medicon Village, Lund, Sweden

All presentations are in English.

Day 1 – Wednesday the 9th of October 2019

08.30–09.00  Registration Symposium
09.00–09.15  Welcome to MVICs Symposium, Lars Asking, MVIC

Generics and New Formulations

Chairman: Lars Asking

09.15–09.55  Wixela Inhub – Road to RegistrationDr Andrew Cooper, Mylan
09.55–10.15  Spray Drying of Sensitive CompoundsGöran Conradsson, Ziccum

10.15–11.10  Coffee and Mingle

Pharmacokinetics and BioEquivalence

Chairman: Dr Bo Olsson

11.10–11.35  No IVIVC and High Between Batch PK Variability – What to do?Dr Dennis Sandell, S5 Consulting AB
11.35–12.05  Regulatory Aspects on Equivalence PK Studies, Erika Fredriksson, Swedish Medical Products Agency, MPA
12.05–12.30  Inhaled BSC (Biopharmaceutical Classification System)Dr Per Bäckman, Emmace Consulting AB

12.30–13.45  Lunch and Mingle


Chairman: Dr Jessica Elversson

13.45–14.10  Controlled Expansion of Supercritical Solutions in Particle EngineeringDr Niklas Sandler, Nanoform
14.10–14.40  Nanoparticulate Systems for Respiratory Delivery, Professor Dr Regina Scherließ, Kiel University

14.40–16.15  Coffee and Mingle

16.15–16.35  Acoustic Monitoring of Inhalation, Dr Johan Bøtker, University of Copenhagen
16.35–16.55  X-ray Computed Tomography: A Non-destructive, Multiscale and 3D Technique for Characterising Inhalation Powders, Dr Parmesh Gajjar, The University of Manchester 
16.55–17.15  Preformulation Studies on Inhalation Raw Material. Solid-state Stability PerspectiveM.Sc. Johanna Husman-Piirainen and Dr Anna Shevchenko, Orion

17.15–17.30  Close and Summary Day 1, Lars Asking, MVIC

17.45–18.30  Drink Reception

18.30  Conference Dinner

Day 2 – Thursday the 10th of October 2019 

Opportunities in Inhaled Drug Delivery

Chairman: Dr Per Bäckman

08.30–09.10  Inhaled Anti-infective Treatments, Dr Igor Gonda, Respidex LLC
09.10–09.40  The Full Story of INBRIJA, Kevin D Kee and Charles Oh, Acorda Therapeutics Inc.

09.40–10.40  Coffee and Mingle

Clinical and Pre-clinical Delivery

Chairman: Dr Karin von Wachenfeldt

10.40–11.05  Inhaled Drug Delivery to HorsesDr Miia Riihimäki, Swedish University of Agricultural Sciences, SLU
11.05–11.30  Isolated, Perfused Lung in Pre-clinical Testing, Johanna Eriksson, Uppsala University
11.30–11.55  Pharmacokinetics (PK) Following Inhalation of Dry Powder Pharmaceuticals to Landrace PigsDr Per Ewing, AstraZeneca

11.55–12.10  Closing Symposium, Lars Asking, MVIC

12.10–13.10  Lunch and Mingle